Palo Alto, CA, United States of America

Hak Kyun Kim

This inventor holds 3 USPTO granted patents. Top assignee: Leland Stanford Junior University. Active years: 2016-2021.


% Patents Active = 66.7

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hak Kyun Kim: Innovator in tRNA-Derived Small RNAs

Introduction

Hak Kyun Kim is a prominent inventor based in Palo Alto, CA (US). He has made significant contributions to the field of molecular biology, particularly in the area of tRNA-derived small RNAs (tsRNAs). With a total of 3 patents, his work has implications for cell viability and apoptosis.

Latest Patents

One of Hak Kyun Kim's latest patents focuses on tRNA-derived small RNAs (tsRNAs) involved in cell viability. This invention features compositions and methods relating to tsRNAs. The patent provides oligonucleotide compositions that are complementary to tsRNAs, specifically leuCAGtsRNA. Additionally, it outlines methods for using these oligonucleotides to regulate respective tsRNAs. Furthermore, the invention includes methods for inducing apoptosis through the inhibition of leuCAGtsRNA.

Career Highlights

Hak Kyun Kim is affiliated with Leland Stanford Junior University, where he conducts his research and development. His innovative work has garnered attention in the scientific community, contributing to advancements in understanding cellular processes.

Collaborations

Some of Hak Kyun Kim's notable coworkers include Mark A Kay and Shengchun Wang. Their collaborative efforts have further enhanced the research and development in the field of tsRNAs.

Conclusion

Hak Kyun Kim's contributions to the field of molecular biology, particularly through his patents on tRNA-derived small RNAs, highlight his role as an influential inventor. His work continues to pave the way for new discoveries in cell viability and apoptosis.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…